ICON Public Limited Company (ICLR)
ICLRNASDAQ-GSBiotechnology: Commercial Physical & Biological Resarch
$204.63
-2.96 (-1.43%) today
At the close, Nov 10, 4:00 PM ET. After hours $206.36 +0.85%
- Market cap
- $15.67bn
- P/E
- 22.1
- EPS, last 4 quarters
- $9.24
- Dividend yield
- –
- Day range
- $200.86 to $206.30
- 52-week range
- $66.57 to $219.04
- Average volume
- 1.07m
- Previous close
- $207.59
Analysts
14 coveringBuy8 buy, 6 hold, 0 sell
Targets a year out average $230.08, +12.4% from here
Earnings
next estimate $2.61Next report
Dec 2025
–
Mar 2026
+2.8%
Jun 2026
+4.0%
Sep 2026
+2.5%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- ICON Public Limited Consensus Price Target Increased by 23.33% to $239.19Fintel · Nov 2, 2026
- What Icon (ICLR) Said on Its Q3 Earnings CallMarketBeat · Oct 28, 2026
- ICON (ICLR) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 28, 2026
- ICON plc Reports $2.15 Billion Senior Notes Issuance and Debt RepaymentsFintel · Oct 27, 2026
- ICON Public Limited Company Reports Third Quarter 2026 ResultsFintel · Oct 27, 2026
- Icon PLC (ICLR) Q3 Earnings and Revenues Beat EstimatesZacks · Oct 27, 2026
- Analysts Estimate Alignment Healthcare (ALHC) to Report a Decline in Earnings: What to Look Out forZacks · Oct 22, 2026
- Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out forZacks · Oct 20, 2026
The company
ICON plc is a world-leading clinical research organisation. Offering deep operational and medical expertise we accelerate innovation, driving emerging therapies forward to improve patient outcomes. From molecule to medicine, we deliver integrated consulting, clinical development, commercialisation and post-marketing solutions to pharmaceutical, biotechnology, medical device, government and public health organisations worldwide. With headquarters in Dublin, Ireland, ICON employed approximately 40,200 employees in 99 locations in 55 countries as at June 30, 2026.
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ-GS
- Region
- Europe
- Website
- iconplc.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.